Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Biol Regul Homeost Agents ; 30(4 Suppl 1): 187-191, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-28002918

RESUMEN

A femoral neck fracture in an elderly patient often represents a major challenge for the orthopaedic surgeon who has to face not only the fracture, but also all the multiple issues related to age. Among others, malnutrition has been recognised as an important factor associated with severe aggravation in these patients. One-hundred-and-forty-seven patients were enrolled to investigate the use of two markers of patient nutritional status, i.e. serum albumin level and total leukocyte count (TLC), as predictors of mortality in the elderly patient suffering from proximal femur fracture. We found that low preoperative values of serum albumin and TLC proved to be directly related to worse outcomes. Therefore, these exams can be useful to identify patients with a femoral neck fracture that have higher risk of malnutrition and consequent higher mortality and that can benefit from some measures, such as albumin or protein nutritional supplement.


Asunto(s)
Fracturas del Cuello Femoral/sangre , Fracturas del Cuello Femoral/mortalidad , Albúmina Sérica/metabolismo , Biomarcadores/sangre , Biomarcadores/metabolismo , Suplementos Dietéticos , Fracturas del Cuello Femoral/cirugía , Humanos , Recuento de Leucocitos , Estado Nutricional , Albúmina Sérica/administración & dosificación , Albúmina Sérica/uso terapéutico
2.
J Clin Endocrinol Metab ; 92(11): 4286-9, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17711926

RESUMEN

BACKGROUND: Chromosomal damage, as assessed by clastogenic factors (CFs) and micronuclei (MN) appearance, after radioiodine therapy of Graves' disease has been reported. OBJECTIVE AND METHODS: Our objective was to evaluate the effect of Ginkgo biloba extract (EGb 761) supplementation on the time course (up to 120 d) of CFs and MN appearance in lymphocytes from patients with Graves' disease after iodine-131 ((131)I) therapy. Patients were randomly assigned to EGb 761 or placebo, in a blinded manner. RESULTS: In the placebo group, MN increased early (P < 0.001) after (131)I, peaking at the 21st day (P = 0.0003) and declining thereafter. In EGb 761-treated patients, MN increased early (P < 0.05), while returning toward baseline value thereafter. Therefore, mean MN increment was significantly higher in the placebo group as compared with EGb 761-treated patients (P < 0.01). Moreover, an early (P < 0.0001) and sustained (up to 35 d; P < 0.001) MN increase induced by CFs was observed in the placebo group. Conversely, in EGb 761-treated patients, MN increase induced by CFs never reached the statistical significance; therefore, the mean of the MN increments was significantly lower than in placebo (P < 0.05). A significant positive correlation between MN maximum increment and the bone marrow dose was observed in the placebo group only (P = 0.03). No significant difference was observed in clinical outcome between the two groups. CONCLUSIONS: EGb 761 supplementation neutralized genotoxic damage induced by radioiodine treatment, without affecting the clinical outcome. Although (131)I therapy is generally safe, our data suggest that Gingko biloba extracts may prevent genetic effects of radioiodine therapy for hyperthyroid Graves' disease.


Asunto(s)
Antimutagênicos/farmacología , Ginkgo biloba/química , Enfermedad de Graves/complicaciones , Enfermedad de Graves/radioterapia , Adulto , Anciano , Antimutagênicos/administración & dosificación , Rotura Cromosómica/efectos de los fármacos , Rotura Cromosómica/efectos de la radiación , Suplementos Dietéticos , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Enfermedad de Graves/genética , Humanos , Radioisótopos de Yodo/uso terapéutico , Linfocitos/efectos de los fármacos , Masculino , Pruebas de Micronúcleos , Persona de Mediana Edad , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Tirotropina/sangre , Tiroxina/sangre , Triyodotironina/sangre
3.
Ann Ital Chir ; 67(3): 347-50, 1996.
Artículo en Italiano | MEDLINE | ID: mdl-9019986

RESUMEN

Post-operative therapy with L-Tiroxine can have a suppressive or substitutional aim. After a total thyroidectomy the patients need a substitutional therapy, while after subtotal thyroidectomy the aim of the therapy is to suppress the TSH secretion. In the second case we want either to avoid the recurrence, either to give the hormones that residual gland cannot produce. The drug of choice is L-Tiroxine for both suppressive o substitutional therapy: There is a difference in dosage, that must be greater in first case. While there are some doubts in the literature on the success of the suppressive therapy, we believe that there is enough evidence of his utility.


Asunto(s)
Bocio Nodular/terapia , Humanos , Cuidados Posoperatorios , Hormonas Tiroideas/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA